Sarai Bronfeld

Sarai Bronfeld has a diverse work experience, starting with their current position as a Principal at NFX, a pre-seed and seed only Venture Capital firm. Sarai previously worked at Winvid as a Business Consultant, where they utilized their expertise to provide consulting services. Sarai also served as a Judge/Mentor at The Zell Entrepreneurship Program at Reichman University. Prior to that, they worked as an Investor at a Family Office, specializing in late-stage and pre-IPO investments. Sarai has also held positions at 2130 Labs as the Head of Business Operations and at TytoCare as a member of the Business Operations team. Sarai began their career at Tel Aviv Medical Center as a Research Scientist, researching the development and metabolism of pancreatic cancer. Sarai also has experience in Israeli intelligence, serving in the IDF as part of the Israeli Intelligence Corps.

Sarai Bronfeld completed a Bachelor's degree in Eastern Asian Studies from Tel Aviv University in 2014. From 2016 to 2018, they pursued pre-medicine/pre-medical studies at Tel Aviv University. Sarai then obtained a Master of Science - MS in Medical Sciences/Graduate Medical Studies from Tel Aviv University between 2018 and 2020. Additionally, in 2015, they participated in a Summer Delegation program at Renmin University of China. Prior to their university education, Sarai attended the May Boyer Arts and Sciences Boarding School for the Gifted and Exceptional until 2009.